Mahesh Sharma

Employment

• Washington DC VA Medical Center Laboratory Director
  2009 - Present
• Drexel University College of Medicine Associate Professor
  2007 - 2009
• Drexel University College of Medicine Assistant Professor
  2001 - 2007

Education

• University of Pennsylvania Postdoctoral
  1992 - 1996
• Fox Chase Cancer Center Postdcotoral
  1991 - 1992
• Central Drug Research Institute PhD
  1987 - 1991
• Chhatrapati Shahu Ji Maharaj University M.Sc
  1985 - 1987
• Chhatrapati Shahu Ji Maharaj University B.Sc.
  1979 - 1982

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers
  International Journal of Cancer 2019 126 citations DOI: 10.1002/ijc.31817
  +Save
• Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer
  Cancer Letters 2016 37 citations DOI: 10.1016/j.canlet.2016.01.013
  +Save
• Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model
  Experimental and Molecular Pathology 2012 69 citations DOI: 10.1016/j.yexmp.2011.10.003
  +Save
• Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation
  Experimental and Molecular Pathology 2010 122 citations DOI: 10.1016/j.yexmp.2010.01.001
  +Save
• Editorial: Pharmaceutical and cellular strategies of recent advances in immunotherapy
  Current Pharmaceutical Design 2009 0 citations DOI: 10.2174/138161209788453176
  +Save
• Inflammation, microenvironment, and the immune system in cancer progression
  Current Pharmaceutical Design 2009 221 citations DOI: 10.2174/138161209788453167
  +Save
• Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5
  Experimental and Molecular Pathology 2007 90 citations DOI: 10.1016/j.yexmp.2006.09.002
  +Save
• The role of annexin II in angiogenesis and tumor progression: A potential therapeutic target
  Current Pharmaceutical Design 2007 134 citations DOI: 10.2174/138161207782794167
  +Save
• Integrin α2β1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein
  Experimental Cell Research 2006 31 citations DOI: 10.1016/j.yexcr.2006.04.009
  +Save
• Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: Possible biochemical mechanism of angiostatin's action
  Experimental and Molecular Pathology 2006 52 citations DOI: 10.1016/j.yexmp.2006.03.002
  +Save